Tingbo Liang (Xueli Bai)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Cataract Surgery

Signaling Pathway

Emergency Medicine

Top Venues

Journal for immunotherapy of cancer

Proceedings of the National Academy of Sciences of the United States of America

Cell death discovery

Annals of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yutong Liu, Ailian Wang, Chen Chen, Qian Zhang, Qin Shen, Dan Zhang, Xueqi Xiao, Shasha Chen, Lili Lian, Zhenmin Le, Shengduo Liu, Tingbo Liang, Qinxiang Zheng, Ping-Long Xu, Jian Zou
Microglial cGAS-STING signaling underlies glaucoma pathogenesis. Proceedings of the National Academy of Sciences of the United States of America 121 (36) (2024)
Qingbo Meng, Yuting Xie, Kang Sun, Lihong He, Hongkun Wu, Qi Zhang, Tingbo Liang
ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion. Cell death discovery 10 (1) (2024)
Yutong Liu, Ailian Wang, Chen Chen, Qian Zhang, Qin Shen, Dan Zhang, Xueqi Xiao, Shasha Chen, Lili Lian, Zhenmin Le, Shengduo Liu, Tingbo Liang, Qinxiang Zheng, Ping-Long Xu, Jian Zou
Microglial cGAS-STING signaling underlies glaucoma pathogenesis. Proceedings of the National Academy of Sciences of the United States of America 121 (36) (2024)
Qingbo Meng, Yuting Xie, Kang Sun, Lihong He, Hongkun Wu, Qi Zhang, Tingbo Liang
ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion. Cell death discovery 10 (1) (2024)
Qihan Fu, Yiwen Chen, Dabing Huang, Chengxiang Guo, Xiaochen Zhang, Wenbo Xiao, Xing Xue, Qi Zhang, Xiang Li, Shunliang Gao, Risheng Que, Yan Shen, Jian Wu, Min Zhang, Tingbo Liang, Tingbo Liang
ASO Visual Abstract: Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial. Annals of surgical oncology (2023)
Jianghui Tang, Jianpeng Sheng, Qi Zhang, Yongtao Ji, Xun Wang, Junlei Zhang, Jiangchao Wu, Jinyuan Song, Xue-Li Bai, Tingbo Liang
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability. Journal for immunotherapy of cancer 11 (2) (2023)
Xiaobo Cai, Xiazhen Yu, Jiawen Yang, Lin Lu, Ning Hua, Xin Duan, Peiwu Ye, Lei Ni, Lin-Hua Jiang, Wei Yang, Tingbo Liang
TRPM2 regulates cell cycle through the Ca2+-CaM-CaMKII signaling pathway to promote HCC. Hepatology communications 7 (5) (2023)
Jianghui Tang, Jianpeng Sheng, Qi Zhang, Yongtao Ji, Xun Wang, Junlei Zhang, Jiangchao Wu, Jinyuan Song, Xue-Li Bai, Tingbo Liang
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability. Journal for immunotherapy of cancer 11 (2) (2023)
Jianghui Tang, Jianpeng Sheng, Qi Zhang, Yongtao Ji, Xun Wang, Junlei Zhang, Jiangchao Wu, Jinyuan Song, Xue-Li Bai, Tingbo Liang
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability. Journal for immunotherapy of cancer 11 (2) (2023)
Qihan Fu, Yiwen Chen, Dabing Huang, Chengxiang Guo, Xiaochen Zhang, Wenbo Xiao, Xing Xue, Qi Zhang, Xiang Li, Shunliang Gao, Risheng Que, Yan Shen, Jian Wu, Min Zhang, Tingbo Liang, Tingbo Liang
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial. Annals of surgical oncology (2023)